3S CORPORATION
Bortezomib Velcade 3

Bortezomib Velcade 3

Send Inquiry

Bortezomib Velcade 3

Bortezomib Velcade 3 for Injection is a single agent indicated for cancer treatment. This intravenous injection is available vial that contains 3.5 mg of bortezomib as a sterile lyophilized powder.

Product Specification:

  • Inactive ingredient: 35 mg Mannitol
  • Chemical Name: (1R)-3-Methyl-1-(2S)-1-OXO-3-Phenyl-2-(Pyrazinecarboxylic) Amino Propyl Amino butyl Boronic Acid

 Features:

  • Bortezomib is a modified dipeptidyl boronic acid
  • The product is provided as a mannitol boronic ester which, in reconstituted form, consists of the mannitol ester in equilibrium with its hydrolysis product, the monomeric boronic acid
  • The drug substance exists in its cyclic anhydride form as a trimeric boroxine